United States
×

www.forbes.com New Breed Of Biotech Investors Show Their Hand With $10 Billion Investment In London Startup LabGenius

In leading the $10 billion investment in LabGenius, two U.S. venture capital funds Lux Capital and Obvious Ventures reveal a biotech investing strategy not seen from the old guard of life science financing.
www.forbes.com
 3

Read also:

www.forbes.com New Breed Of Biotech Investors Show Their Hand With $10 Million Investment In London Startup LabGeniuswww.forbes.com